Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001724521-23-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-05 | 2023-12-01 | RCUS | Azoy Alexander | CAO | S - Sale | $14.95 | -282 | 11.6K | -2% | -$4,216 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | S | D | 282 | $14.95 | 11,596 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 30, 2023. (F2) Consists of 282 shares purchased on 11/30/2023 through the Company's Employee Stock Purchase Plan. |